Back

AI vaccine adjuvant funding exceeds $140M, BCC Research report says

Verifying
  • BCC Research released a report on AI's impact on vaccine adjuvant development.
  • Recent disclosed transactions exceeded $140M, including Pfizer-NVIDIA and Ginkgo Bioworks-SaponiQx deals.
  • The report lists regulatory, infrastructure, talent and funding-tracking challenges limiting sector expansion.
The information on this website is generated using AI and we cannot guarantee its accuracy. Please use it as reference information only.